Riskpilot← Back to searchSign inGet full accessCRYOGENETICS AS
ASActiveOrg 985283885Storhamargata 44, 2317 HamarResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200326 employeeswww.cryogentics.no
Revenue 2024
NOK 34,7M
+6% vs 2023
EBITDA margin
-6.9%
-123% vs 2023
Equity ratio
63.8%
Financial strength
Net profit 2024
NOK -4,3M
-171% vs 2023
| Revenue | NOK 34,7M | +6% |
| EBITDA | NOK -2,4M | -123% |
| Net profit | NOK -4,3M | -171% |
| Total assets | NOK 53,5M | -5% |
| Equity | NOK 34,1M | -11% |
| Employees | 26 | — |
Legal name
CRYOGENETICS AS
Org number
985283885
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18. februar 2003
Share capital
NOK 4 428 320
Employees
26 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Å drive utvikling og salg av produkter og tjenester tilknyttet behandling av melke, frysing og lagring av genetisk materiale fra akvatiske organismer og naturlig tilhørende virksomhet.
Address
Storhamargata 44, 2317 Hamar
Website
www.cryogentics.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 973 | 2 327 | 3 610 | 3 612 | 8 202 | 6 491 | 9 300 | 15 460 | 22 587 | 13 732 | 14 614 | 18 839 | 20 769 | 22 836 | 32 654 | 34 694 |
| Staff expenses | −0 | −0 | −128 | −35 | −938 | −2 095 | −4 617 | −5 136 | −5 438 | −6 293 | −7 336 | −5 681 | −6 457 | −7 348 | −7 156 | −8 159 | −8 646 | −21 190 |
| EBITDA | 0 | 0 | −1 127 | 598 | −1 568 | −1 077 | −839 | −2 387 | −2 073 | −2 770 | 4 856 | 457 | 1 721 | 4 255 | 3 999 | 1 617 | 10 336 | −2 378 |
| Depreciation & amort. | −0 | −0 | −68 | −128 | −610 | −995 | −2 049 | −3 384 | −3 680 | −11 496 | −1 999 | −1 572 | −1 447 | −1 542 | −1 534 | −1 695 | −2 351 | −3 405 |
| EBIT | 0 | 0 | −1 195 | 470 | −2 178 | −2 072 | −2 888 | −5 772 | −5 752 | −14 266 | 2 857 | −1 115 | 274 | 2 713 | 2 465 | −78 | 7 985 | −5 782 |
| Net financials | 0 | 0 | 12 | −55 | −225 | −666 | −228 | 2 924 | 3 554 | −22 601 | −580 | 711 | 1 498 | 767 | 1 231 | 733 | −482 | −127 |
| Profit before tax | 0 | 0 | −1 183 | 415 | −2 403 | −2 738 | −3 116 | −2 848 | −2 198 | −36 867 | 2 277 | −404 | 1 772 | 3 480 | 3 696 | 655 | 7 503 | −5 910 |
| Tax | −0 | −0 | −371 | 96 | −750 | −924 | −937 | −955 | −420 | −4 490 | 851 | 74 | 212 | 685 | 611 | −52 | 1 446 | −1 590 |
| Net profit | 0 | 0 | −812 | 319 | −1 653 | −1 814 | −2 179 | −1 893 | −1 779 | −32 377 | 1 426 | −478 | 1 560 | 2 795 | 3 085 | 707 | 6 057 | −4 320 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | 1 538 | 6 209 | 16 494 | 29 486 | 43 658 | 64 823 | 62 506 | 42 910 | 42 498 | 37 328 | 38 802 | 45 463 | 46 279 | 51 234 | 56 509 | 53 464 |
| Equity | — | — | 598 | 917 | 3 264 | 15 960 | 25 781 | 47 048 | 45 270 | 22 893 | 24 318 | 23 840 | 25 399 | 28 598 | 31 683 | 32 390 | 38 447 | 34 127 |
| Long-term debt | 0 | 0 | 694 | −294 | −372 | 10 993 | 13 891 | 13 946 | 12 268 | 12 867 | 9 225 | 6 843 | 8 535 | 10 291 | 9 331 | 10 252 | 11 085 | 9 558 |
| Short-term debt | 0 | 0 | 246 | 1 499 | 2 813 | 2 533 | 3 986 | 3 828 | 4 968 | 7 151 | 8 446 | 6 391 | 4 719 | 6 475 | 5 168 | 8 591 | 6 977 | 9 778 |
| Total debt | 0 | 0 | 940 | 4 999 | 12 858 | 13 526 | 17 877 | 17 775 | 17 236 | 20 018 | 17 671 | 13 234 | 13 254 | 16 766 | 14 499 | 18 843 | 18 062 | 19 336 |
EBITDA margin
-6.9%
This company
15.8%
Market median
-144% vs market
20072024
Equity ratio
63.8%
This company
38.2%
Market median
+67% vs market
20072024
Return on equity
-12.7%
This company
18.4%
Market median
-169% vs market
20072024
Net profit margin
-12.5%
This company
8.1%
Market median
-254% vs market
20072024
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20072024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ES Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
PS Deputy Member | Deputy Member | 2021 | — | — |
RV Observer | Observer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Geno Sa | Company | 50.0% | 50.0% | 2024 |
Investinor Direkte As | Company | 37.3% | 37.3% | 2024 |
Cryo Invest As | Company | 12.8% | 12.8% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NÆRINGS- OG FISKERIDEPARTEMENTET
CRYOGENETICS AS Board members of CRYOGENETICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eli Sætersmoen | Chief Executive Officer | 0 companies |
| Pål Sommer Breiland | Deputy Member | 0 companies |
| Ronny Vikdal | Observer | 0 companies |
| Alf-Helge Aarskog | Board of Directors | 0 companies |
| Karina Wessel | Board of Directors | 0 companies |
| Torbjørn Almlid | Board of Directors | 0 companies |
| Otto Søberg | Chairman | 0 companies |
| Kristin Malonæs | Board of Directors | 0 companies |
| Even Søfteland | Chairman | 0 companies |
| Kjetil Haga | Board of Directors | 0 companies |